Palforzia becomes first peanut allergy drug to get US approval
The approval marks a “defining moment” for the peanut allergy community.
5th February 2020
Latest news
Survey reveals ‘key barriers’ limiting PCSK9is prescribing
Just 6% of cardiologists are currently prescribing PCSK9is, despite 97% believing in their abilities.
5th February 2020
NICE to request Aimovig evidence, appeal panel rules
NICE initially rejected NHS funding for the monoclonal antibody in January last year, deeming it “too costly” for the service.
4th February 2020
RCPE launches strategy to improve health & patient care
The “ambitious” new strategy is dubbed “Towards 2025 Together".
4th February 2020
UK coronavirus info campaign launched
By last Tuesday, the death toll in China stood at more than 420, and the Chinese government had reported 20,438 confirmed cases.
4th February 2020
BMS withdraws EU Opdivo/Yervoy application
The application was initially filed in 2018 for patients with first-line NSCLC.
4th February 2020
GSK to join global effort to develop coronavirus vaccine
Last week WHO declared the outbreak an official global health emergency.
4th February 2020
Rinvoq NICE approval could benefit 54,000 people
Rinvoq has already been available in the US since last August, and in Europe since December.
3rd February 2020
EMA accepts GSK’s belantamab mafodotin application
The drug was also accepted for accelerated assessment by the EMA’s Committee for Human Medicinal Products (CHMP).
3rd February 2020
Pharmacists voice concerns over Brexit medicine supplies
The survey found that almost nine in 10 pharmacists are concerned about the supply of medicines now that Brexit is underway.
3rd February 2020
Could ‘tailor-made’ vaccines halve bacterial disease rates?
The findings coincide with growing alarm at the threat of antimicrobial resistance (AMR) to common medicines, after last year a UN report revealed that if left unchecked, AMR could cause as many as 10 million deaths per year by 2050.
3rd February 2020
Givlaari, Nubeqa among Jan CHMP decisions
The committee recommended fifteen medicines for approval at its first meeting of 2020, as well as six extensions of current indications.
3rd February 2020
60% of UK unis expect Brexit to affect pharma industry relationships
The UK is expected to officially leave the European Union at 11PM tonight, January 31st.
31st January 2020
Nubeqa success in Phase III prostate cancer study
"A positive trend in overall survival" had been seen in a trial, with an interim analysis demonstrating a 29% reduction in the risk of death for Nubeqa.
31st January 2020
LEO issues Picato recall
Last September, the EMA's Pharmacovigilance Risk Assessment Committee announced a review of data on skin cancer in patients using the drug.
31st January 2020
